ZA200903236B - Neuronal exocytosis inhibiting peptides - Google Patents

Neuronal exocytosis inhibiting peptides

Info

Publication number: ZA200903236B
Authority: ZA; South Africa
Prior art keywords: inhibiting peptides; neuronal exocytosis; exocytosis inhibiting; neuronal; peptides
Prior art date: 2006-10-25

Application number

ZA200903236A

Other languages

English (en)

Inventor

Serraima C Carreno

Obiols Berta Ponsati

Den Nest Wim Van

Carneado Jimena Fernandez

Montiel Antonio Ferrer

Puche Joan Cebrian

Domenech Nuria Aliminana

Original Assignee

Lipotec Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2006-10-25

Filing date

2007-10-24

Publication date

2010-07-28

2007-10-24 Application filed by Lipotec Sa filed Critical Lipotec Sa

2010-07-28 Publication of ZA200903236B publication Critical patent/ZA200903236B/xx

Links

230000028023 exocytosis Effects 0.000 title 1
230000002401 inhibitory effect Effects 0.000 title 1
230000001537 neural effect Effects 0.000 title 1
102000004196 processed proteins & peptides Human genes 0.000 title 1
108090000765 processed proteins & peptides Proteins 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/14—Liposomes; Vesicles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/10—Washing or bathing preparations
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
Dermatology (AREA)
Epidemiology (AREA)
Birds (AREA)
Engineering & Computer Science (AREA)
Pharmacology & Pharmacy (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Cell Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Toxicology (AREA)
Zoology (AREA)
Gastroenterology & Hepatology (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Genetics & Genomics (AREA)
Molecular Biology (AREA)
Immunology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Biomedical Technology (AREA)
Peptides Or Proteins (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Cosmetics (AREA)
Medicinal Preparation (AREA)

ZA200903236A 2006-10-25 2007-10-24 Neuronal exocytosis inhibiting peptides ZA200903236B (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
ES200602720A ES2322882B1 (es)	2006-10-25	2006-10-25	Peptidos inhibidores de la exocitosis neuronal.

Publications (1)

Publication Number	Publication Date
ZA200903236B true ZA200903236B (en)	2010-07-28

Family

ID=39324166

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ZA200903236A ZA200903236B (en)	2006-10-25	2007-10-24	Neuronal exocytosis inhibiting peptides

Country Status (28)

Country	Link
US (1)	US9464129B2 (xx)
EP (1)	EP2123673B1 (xx)
JP (1)	JP5647413B2 (xx)
KR (1)	KR101606448B1 (xx)
CN (1)	CN101541831B (xx)
AR (1)	AR063528A1 (xx)
AU (1)	AU2007310796B2 (xx)
BR (1)	BRPI0717376B8 (xx)
CA (1)	CA2666516C (xx)
CL (1)	CL2007003054A1 (xx)
CY (1)	CY1118690T1 (xx)
DK (1)	DK2123673T3 (xx)
ES (2)	ES2322882B1 (xx)
HK (1)	HK1132999A1 (xx)
HR (1)	HRP20170378T1 (xx)
HU (1)	HUE031340T2 (xx)
IL (1)	IL198191A (xx)
LT (1)	LT2123673T (xx)
MX (1)	MX2009004424A (xx)
NZ (1)	NZ576373A (xx)
PL (1)	PL2123673T3 (xx)
PT (1)	PT2123673T (xx)
RS (1)	RS55755B1 (xx)
RU (1)	RU2461568C2 (xx)
SI (1)	SI2123673T1 (xx)
TW (1)	TWI439291B (xx)
WO (1)	WO2008049945A1 (xx)
ZA (1)	ZA200903236B (xx)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5019016A (en)	1990-04-10	1991-05-28	Gkn Automotive Inc.	Anti-shudder tripod constant velocity universal joint
ES2356883B1 (es) *	2008-07-24	2012-02-22	Bcn Peptides, S.A.	Composición para el tratamiento del dolor y/o la inflamación.
US20110305735A1 (en) *	2010-06-09	2011-12-15	Lipotec, S.A.	Skin antiaging treatment
FR2961510A1 (fr) *	2010-06-17	2011-12-23	Oreal	Utilisation comme agent de traitement de la transpiration humaine ; nouveaux derives d'acide amine ; compositions les contenant
ES2385683B1 (es) *	2010-10-18	2013-10-07	Bcn Peptides, S.A.	Composiciones para el tratamiento del dolor y/o la inflamación.
EP2637635A1 (de) *	2010-11-12	2013-09-18	La Prairie Group AG	Kosmetische und/oder dermatologische zubereitungen enthaltend schneealgenextrakt
EP2802337B2 (en) *	2011-11-07	2021-01-20	Feng Tian	Peptide-based compounds as inhibitors of neurotransmitter secretion
ES2424294B1 (es)	2012-03-22	2014-07-21	Lipotec, S.A.	Exopolisacárido para el tratamiento y/o cuidado de la piel, mucosas, cabello y/o uñas
EP2649985A1 (en)	2012-04-13	2013-10-16	Lipotec, S.A.	Compounds which inhibit neuronal exocytosis (III)
ES2660901T3 (es)	2012-04-13	2018-03-26	Lubrizol Advanced Materials, Inc.	Compuestos que inhiben la exocitosis neuronal (II)
EP2649984A1 (en) *	2012-04-13	2013-10-16	Lipotec, S.A.	Compounds which inhibit neuronal exocytosis
CN104334155B (zh)	2012-04-13	2017-06-16	艾克迪文	包含μ芋螺肽的化妆品组合物
EP2649983A1 (en)	2012-04-13	2013-10-16	Lipotec, S.A.	Compounds which inhibit neuronal exocytosis (II)
US10149812B2 (en)	2012-04-13	2018-12-11	Activen	Cosmetic composition comprising a muconopeptide
HUE034308T2 (en)	2013-03-21	2018-02-28	Sanofi Aventis Deutschland	Preparation of hydantoin-containing peptide products
CA2907521C (en)	2013-03-21	2021-04-13	Sanofi-Aventis Deutschland Gmbh	Synthesis of cyclic imide containing peptide products
US20160250298A1 (en)	2013-11-01	2016-09-01	Spherium Biomed S.L.	Inclusion bodies for transdermal delivery of therapeutic and cosmetic agents
CN103641888B (zh) *	2013-12-03	2015-08-12	广州健坤生物科技有限公司	一种多功能新型小肽、包含该肽的组合物及其应用
CN103637925B (zh) *	2013-12-03	2015-09-30	广州健坤生物科技有限公司	γ-氨基丁酸(GABA)和一种小肽在化妆品中的联合应用
CN103694316B (zh) *	2013-12-31	2015-09-09	杭州华津药业股份有限公司	一种阿基瑞林的制备方法
RU2551276C1 (ru) *	2014-02-03	2015-05-20	Закрытое Акционерное Общество "Фарм-Синтез"	Способ получения диацетата трипептида
EP2952205B1 (en) *	2014-06-06	2017-08-09	Kleiner-Fisman, Galit	Botulinum toxin for use in the treatment of paratonia
CA2965525A1 (en)	2014-10-31	2016-05-06	Lubrizol Advanced Materials, Inc.	Thermoplastic polyurethane film for delivery of active agents to skin surfaces
KR101747411B1 (ko) *	2015-04-13	2017-06-14	주식회사 엘지생활건강	신경전달물질을 조절하는 펩타이드의 신경세포 전달용 용해성 미세바늘
US20180311358A1 (en)	2015-11-05	2018-11-01	Lubrizol Advanced Materials, Inc.	Thermoformable dual network hydrogel compositions
RU2633691C2 (ru) *	2015-12-17	2017-10-16	Федеральное государственное автономное образовательное учреждение высшего образования "Балтийский федеральный университет имени Иммануила Канта" (БФУ им. И. Канта)	Способ генетического контроля экзоцитоза на основе генетических конструкций для трансфекции клеток астроглии
KR101895906B1 (ko) *	2016-07-07	2018-10-04	주식회사 한국화장품제조	펩타이드 리포좀을 포함하는 스틱형 화장료 조성물
KR102607079B1 (ko) *	2016-09-09	2023-11-28	주식회사 엘지생활건강	신경세포 투과성이 향상된 신경전달물질 조절 펩타이드
JP7227903B2 (ja) *	2016-11-30	2023-02-22	ルブリゾルアドバンスドマテリアルズ，インコーポレイテッド	皮膚、毛髪、爪および／もしくは粘膜の処置ならびに／またはケアに有用な化合物
US11129906B1 (en)	2016-12-07	2021-09-28	David Gordon Bermudes	Chimeric protein toxins for expression by therapeutic bacteria
CN110997696B (zh) *	2017-06-28	2024-03-05	株式会社Lg生活健康	包含结合有皮肤渗透促进用肽的融合蛋白的皮肤改善用化妆料组合物
WO2019166347A1 (en)	2018-02-27	2019-09-06	Lipotrue, S.L.	Peptides and compositions for use in cosmetics and medicine
JP7488198B2 (ja) *	2018-06-13	2024-05-21	アジェンデ・キミケ・リウニテ・アンジェリニ・フランチェスコ・ア・チ・エレ・ア・エフェ・ソシエタ・ペル・アチオニ	神経細胞エキソサイトーシスに対して阻害活性を有するペプチド
CN109021071B (zh) *	2018-08-21	2020-08-04	山西锦波生物医药股份有限公司	肽及其制备方法和用途
EP3831358B1 (en) *	2019-12-04	2025-03-12	Lipotrue, S.L.	Peptides and compositions for use in cosmetics and medicine
WO2022162312A1 (fr) *	2021-01-27	2022-08-04	Fabien Schweighoffer	Peptides et leurs utilisations
CN113512092A (zh) *	2021-06-28	2021-10-19	陕西未来多肽生物科技有限公司	多肽纳米杂化物及其用途
CN113402586A (zh) *	2021-06-28	2021-09-17	陕西未来多肽生物科技有限公司	一种多肽及其应用
CN113929749B (zh) *	2021-11-18	2024-08-09	陕西未来多肽生物科技有限公司	一种十六肽化合物及其制备方法
CN114933634B (zh) *	2021-11-18	2024-08-09	陕西未来多肽生物科技有限公司	一种乙酰基十六肽的合成方法
EP4230638A1 (en)	2022-02-16	2023-08-23	Lipotrue, S.L.	Peptides and compositions for use in cosmetics
WO2023155881A1 (en) *	2022-02-18	2023-08-24	Tsinghua University	Methods for regulating secretion via migrasomes
WO2023184114A1 (zh)	2022-03-28	2023-10-05	深圳市维琪科技股份有限公司	一种多肽及其美容组合物或药用组合物和用途
WO2024011300A1 (en) *	2022-07-13	2024-01-18	L'oreal	Modified peptides, composition, method for inhibiting contraction of muscle cells, method for improving the skin and use of a modified peptide

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0258111A3 (en) *	1986-08-07	1989-01-25	FIDIA S.p.A.	Novel neuronotrophic factor
JPH04218374A (ja) *	1990-03-14	1992-08-07	Fidia Spa	ヒト毛様体神経栄養因子
WO1997034620A1 (en)	1996-03-18	1997-09-25	The Regents Of The University Of California	Peptide inhibitors of neurotransmitter secretion by neuronal cells
ES2160485B1 (es) *	1999-04-23	2002-05-16	Lipotec Sa	Peptidos inhibidores de la exocitosis neuronal, composiciones cosmeticas y farmaceuticas que los contienen.
KR101116528B1 (ko) *	2003-05-08	2012-02-28	디에스엠 아이피 어셋츠 비.브이.	피부구조를 향상시키는 트리펩타이드 및 그 유도체의 미용용도
ES2293753B1 (es) *	2004-04-28	2009-03-16	Lipotec, S.A.	Uso de peptidos xikvav en preparacion de composiciones cosmeticas para mejorar la firmeza de la piel mediante el aumento de la adhesion celular.
EP1856139B1 (en) *	2005-03-03	2011-04-27	Revance Therapeutics, Inc.	Compositions and methods for topical application and transdermal delivery of an oligopeptide
ES2259928B1 (es) *	2005-04-08	2007-11-01	Lipotec, S.A.	Composicion cosmetica o dermofarmaceutica que comprende peptidos derivados de encefalinas para reducir y/o eliminar arrugas faciales.
US7807625B2 (en) *	2006-01-18	2010-10-05	Grant Industries, Inc	Anti-wrinkle composition

2006
- 2006-10-25 ES ES200602720A patent/ES2322882B1/es active Active
2007
- 2007-10-23 AR ARP070104688A patent/AR063528A1/es unknown
- 2007-10-24 KR KR1020097009786A patent/KR101606448B1/ko active Active
- 2007-10-24 DK DK07823010.9T patent/DK2123673T3/en active
- 2007-10-24 HU HUE07823010A patent/HUE031340T2/en unknown
- 2007-10-24 EP EP07823010.9A patent/EP2123673B1/en active Active
- 2007-10-24 TW TW096139868A patent/TWI439291B/zh active
- 2007-10-24 PL PL07823010T patent/PL2123673T3/pl unknown
- 2007-10-24 RU RU2009114804/04A patent/RU2461568C2/ru active
- 2007-10-24 WO PCT/ES2007/000603 patent/WO2008049945A1/es active Application Filing
- 2007-10-24 AU AU2007310796A patent/AU2007310796B2/en active Active
- 2007-10-24 NZ NZ576373A patent/NZ576373A/en unknown
- 2007-10-24 RS RS20170242A patent/RS55755B1/sr unknown
- 2007-10-24 SI SI200731897A patent/SI2123673T1/sl unknown
- 2007-10-24 JP JP2009533889A patent/JP5647413B2/ja active Active
- 2007-10-24 PT PT78230109T patent/PT2123673T/pt unknown
- 2007-10-24 MX MX2009004424A patent/MX2009004424A/es active IP Right Grant
- 2007-10-24 CL CL200703054A patent/CL2007003054A1/es unknown
- 2007-10-24 CN CN200780043641.3A patent/CN101541831B/zh active Active
- 2007-10-24 BR BRPI0717376A patent/BRPI0717376B8/pt active IP Right Grant
- 2007-10-24 LT LTEP07823010.9T patent/LT2123673T/lt unknown
- 2007-10-24 ES ES07823010.9T patent/ES2638286T3/es active Active
- 2007-10-24 US US12/447,136 patent/US9464129B2/en active Active
- 2007-10-24 CA CA2666516A patent/CA2666516C/en active Active
- 2007-10-24 ZA ZA200903236A patent/ZA200903236B/xx unknown
2009
- 2009-04-19 IL IL198191A patent/IL198191A/en active IP Right Grant
- 2009-11-27 HK HK09111102.3A patent/HK1132999A1/xx unknown
2017
- 2017-03-02 CY CY20171100275T patent/CY1118690T1/el unknown
- 2017-03-07 HR HRP20170378TT patent/HRP20170378T1/hr unknown

Also Published As

Publication number	Publication date
TWI439291B (zh)	2014-06-01
PT2123673T (pt)	2017-03-01
LT2123673T (lt)	2017-03-27
RS55755B1 (sr)	2017-07-31
TW200833365A (en)	2008-08-16
CL2007003054A1 (es)	2008-03-24
US20100021510A1 (en)	2010-01-28
NZ576373A (en)	2011-11-25
ES2638286T3 (es)	2017-10-19
CY1118690T1 (el)	2017-07-12
EP2123673A4 (en)	2011-01-12
IL198191A0 (en)	2011-08-01
ES2322882B1 (es)	2010-04-22
AR063528A1 (es)	2009-01-28
KR101606448B1 (ko)	2016-03-25
MX2009004424A (es)	2009-05-11
HUE031340T2 (en)	2017-07-28
CA2666516C (en)	2017-06-13
EP2123673B1 (en)	2016-12-07
RU2009114804A (ru)	2010-11-27
WO2008049945A1 (es)	2008-05-02
BRPI0717376B8 (pt)	2021-05-25
CA2666516A1 (en)	2008-05-02
CN101541831A (zh)	2009-09-23
AU2007310796A1 (en)	2008-05-02
RU2461568C2 (ru)	2012-09-20
AU2007310796B2 (en)	2013-10-10
PL2123673T3 (pl)	2017-06-30
DK2123673T3 (en)	2017-03-20
JP5647413B2 (ja)	2014-12-24
EP2123673A1 (en)	2009-11-25
IL198191A (en)	2016-07-31
SI2123673T1 (sl)	2017-07-31
HRP20170378T1 (hr)	2017-05-05
US9464129B2 (en)	2016-10-11
BRPI0717376B1 (pt)	2018-07-24
BRPI0717376A2 (pt)	2013-10-29
JP2010507632A (ja)	2010-03-11
KR20090090307A (ko)	2009-08-25
HK1132999A1 (en)	2010-03-12
ES2322882A1 (es)	2009-06-30
CN101541831B (zh)	2015-04-01

Publication	Publication Date	Title
ZA200903236B (en)	2010-07-28	Neuronal exocytosis inhibiting peptides
HK1169089A1 (en)	2013-01-18	Logistics system
GB0716377D0 (en)	2007-10-03	Dust-extracting system
EP2017283A4 (en)	2015-12-30	Peptides
GB0614332D0 (en)	2006-08-30	System
GB0723712D0 (en)	2008-01-16	Peptides
HK1139421A1 (en)	2010-09-17	Antibacterial peptides
EP2029448A4 (en)	2009-12-09	TRANSPORT APPARATUS
PL2059451T3 (pl)	2015-09-30	System zamykania
GB0602276D0 (en)	2006-03-15	System
PL2008251T3 (pl)	2014-02-28	Element zabezpieczający
EP2123666A4 (en)	2011-01-05	PEPTIDE
GB0620302D0 (en)	2006-11-22	Hugslock system
GB0616494D0 (en)	2006-09-27	Armour
GB0618748D0 (en)	2006-11-01	Peptide
GB0621015D0 (en)	2006-11-29	Seismography system
GB0614336D0 (en)	2006-08-30	System
GB0703945D0 (en)	2007-04-11	Peptide
EP2188305A4 (en)	2010-08-18	MODIFIED PEPTIDES HAVING TOXIN IMPROVING EFFECTS
GB0605774D0 (en)	2006-05-03	Peptide
IL197675A0 (en)	2009-12-24	Peptides
GB0614335D0 (en)	2006-08-30	System
GB0607805D0 (en)	2006-05-31	Fluxion system
GB0618512D0 (en)	2006-11-01	Peptides
GB0609921D0 (en)	2006-06-28	Peptides